Blau Farmacêutica S.A. (BVMF:BLAU3)

Market Cap	2.31B
Revenue (ttm)	1.77B
Net Income (ttm)	324.56M
Shares Out	177.68M
EPS (ttm)	1.82
PE Ratio	7.14
Forward PE	7.54
Dividend	0.46 (3.55%)
Ex-Dividend Date	Dec 19, 2025

Volume	164,700
Average Volume	365,885
Open	13.01
Previous Close	13.02
Day's Range	12.92 - 13.10
52-Week Range	11.48 - 14.71
Beta	0.40
RSI	50.11
Earnings Date	Mar 18, 2026

About Blau Farmacêutica

Blau Farmacêutica S.A., a pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its products cover various areas, such as immunology, hematology, oncology, nephrology, infectology, and anesthesiology. The company offers uterine stimulator, antirheumatic, anaesthetics, antibiotics, feminine health care, biopharmaceuticals, oncologicals, hospital products, antivirals and antiretrovirals, biológicos, acid pump inhibitor, hemoderivatives, antithrombotic, and thrombolytics...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 1,900
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: BLAU3

Financial Performance

In 2024, Blau Farmacêutica's revenue was 1.75 billion, an increase of 27.81% compared to the previous year's 1.37 billion. Earnings were 217.21 million, a decrease of -13.05%.